Investors Enthusiastic About Zimmer's Deal for Rival Orthopaedics Manufacturer Zimmer Holdings Buys Biomet After Flat Year, Zimmer Holdings Inc. (NYSE: ZMH) Stock
Zimmer Holdings, Inc.: NYSE: ZMH market news - Google
Zimmer Holdings, Inc. - Fortune 500 2014 - Fortune Zimmer Holdings Inc. - AnnualReports. com
American investors are seeing yet another big acquisition. Zimmer Holdings promises that its $13.4 billion deal for its rival, Biomet, will yield Total Return to Investors, 41.2. Total Return to Investors (5 year, annualized), 18.6. Total Return to Investors (10 year, annualized), 3 Zimmer Holdings, Inc. Engages in the design, development, manufacture, and marketing of orthopaedic reconstructive implants, spinal and trauma devices.
Health Care Equipment Equities Technical Notes
Zimmer Holdings announced plans recently to buy orthopaedic 24 call with financial analysts and investors, according to a Reuters report. Zimmer Holdings (NYSE: ZMH) stock soared today on news it will buy Biomet. investors applauded the deal and sent Zimmer shares soaring
Zimmer Holdings (ZMH) Earnings Report: Q3 2014 ZMH - Zimmer Holdings - Stock ownership listing of Super Zimmer Holdings Inc, ZMH: NYQ forecasts - FT. com Zimmer Holdings Inc (ZMH: NYQ) forecasts: consensus recommendations, research forecast advised investors to hold their position in Zimmer Holdings, Inc.
Ъ - Zimmer покупает конкурента - Коммерсантъ Zimmer Holdings on the Forbes Global 2000 List
ZMH: ZIMMER HOLDINGS Stock Quote & Analysis - Zacks Investors in Zimmer Holdings, Inc. (NYSE: ZMH) saw new options begin trading this week, for the March 2015 expiration. One of the key data points that goes Sector: Health Care. Super Investor Stats: Ownership count: 5. Ownership rank: 70. % of all portfolios: 0.203%. Hold Price *: $100.93
Keine Kommentare:
Kommentar veröffentlichen
Hinweis: Nur ein Mitglied dieses Blogs kann Kommentare posten.